Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
VaccinesVeterinary Medicine

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1747882

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1747882

Pet Vaccines

PUBLISHED:
PAGES: 271 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Pet Vaccines Market to Reach US$9.1 Billion by 2030

The global market for Pet Vaccines estimated at US$7.1 Billion in the year 2024, is expected to reach US$9.1 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Canlane Vaccines, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$6.0 Billion by the end of the analysis period. Growth in the Feline Vaccines segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 7.3% CAGR

The Pet Vaccines market in the U.S. is estimated at US$1.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 7.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Pet Vaccines Market - Key Trends & Drivers Summarized

Why Are Pet Vaccines Critical in the Era of Zoonotic Risk Awareness and Preventive Veterinary Care?

Pet vaccines are experiencing rising demand globally as pet owners, veterinarians, and public health authorities place stronger emphasis on disease prevention, longevity, and zoonotic risk mitigation. Vaccines form the frontline defense against contagious and potentially fatal diseases such as rabies, distemper, parvovirus, feline leukemia, and kennel cough. With increased urbanization and closer human-pet cohabitation, immunization is no longer just a veterinary recommendation-it’s a regulatory and ethical imperative in companion animal care.

The COVID-19 pandemic has elevated awareness of interspecies disease transmission, pushing both governments and individuals to adhere more strictly to vaccination schedules. In many jurisdictions, rabies vaccination is mandatory, while others require proof of immunization for boarding, travel, and adoption. These regulations, along with broader efforts to professionalize pet healthcare, are reinforcing the role of core and non-core vaccines as standard components of wellness protocols across cats, dogs, and exotic companion animals.

How Are Innovations in Delivery Methods, Formulations, and Combination Vaccines Enhancing Compliance?

Technological advances in vaccine formulation and delivery are improving efficacy, reducing side effects, and enhancing compliance among pet owners and veterinarians. Modified-live virus (MLV) and recombinant vaccines now offer broader immune protection with fewer adverse reactions. Intranasal and transdermal delivery systems are also being developed to minimize injection site discomfort and stress, particularly in cats and small-breed dogs.

Combination vaccines, such as DAPP (Distemper, Adenovirus, Parainfluenza, Parvovirus) or FVRCP (Feline Viral Rhinotracheitis, Calicivirus, Panleukopenia), are gaining wide acceptance for their convenience and broad-spectrum protection. These formulations reduce the number of veterinary visits and injections required, improving owner adherence and animal welfare. Additionally, manufacturers are investing in adjuvant technologies that enhance immune response while minimizing inflammation or allergic reactions, especially in pets with chronic health conditions or advanced age.

Why Are Companion Animal Healthcare Ecosystems and Emerging Market Dynamics Driving Access and Uptake?

The rise of organized veterinary care networks, mobile vaccination clinics, pet insurance coverage, and smart scheduling apps is enabling wider access to pet vaccines. Wellness plans bundled with annual check-ups are now common in North America and Europe, encouraging consistent immunization. Meanwhile, in emerging economies such as India, Brazil, and Southeast Asia, rising incomes and urban pet adoption are triggering demand for affordable, government-supported immunization programs.

Non-governmental organizations (NGOs), international animal welfare agencies, and public health authorities are also playing a pivotal role in extending vaccination coverage in underserved areas. Mass rabies vaccination campaigns, street dog immunization drives, and educational initiatives are creating scalable models for community-wide disease prevention. Veterinary telemedicine, doorstep services, and e-pharmacy platforms are making vaccine access more streamlined and less intimidating for pet owners.

What’s Fueling the Global Expansion of the Pet Vaccines Market?

The growth in the pet vaccines market is driven by several factors including the increasing global pet population, heightened awareness of zoonotic diseases, and the proliferation of organized pet healthcare frameworks. A major growth driver is the integration of preventive care into standard veterinary services and consumer expectations-shifting the focus from reactive treatment to proactive disease management.

Advancements in vaccine technology, expansion of veterinary infrastructure, and public-private initiatives in both developed and developing markets are creating a robust demand environment. With the convergence of regulatory support, digital healthcare integration, and consumer-driven spending on pet wellness, the pet vaccines market is positioned for sustained global growth. As immunization becomes central to responsible pet parenting and population health strategy, vaccines will remain the cornerstone of preventive veterinary medicine.

SCOPE OF STUDY:

The report analyzes the Pet Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Canlane, Feline); Application (Dogs, Cats, Rabbits, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Bayer AG
  • Bimeda Biologicals
  • Boehringer Ingelheim
  • Calier
  • Ceva Sante Animale
  • China Animal Husbandry Industry Co., Ltd.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health
  • Hester Biosciences Limited
  • HIPRA
  • Intervet (MSD Animal Health)
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Sanofi
  • Tianjin Ringpu Biotechnology Co., Ltd.
  • Vaxxinova
  • Veterquimica
  • Vetoquinol
  • Virbac
  • Zoetis Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Show more
Product Code: MCP35512

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Pet Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Pet Ownership and Companion Animal Spending Drives Demand for Preventive Veterinary Vaccinations
    • Expansion of Companion Animal Zoonosis Awareness Throws the Spotlight on Core and Non-Core Pet Vaccines
    • OEM Innovation in Recombinant and DNA-Based Pet Vaccines Enhances Safety and Immune Efficacy
    • Growth in Veterinary Clinics and Pet Hospitals Expands Vaccination Accessibility Across Urban and Rural Areas
    • OEM Collaboration With Animal Health Organizations Supports Development of Multivalent Vaccine Protocols
    • Surge in Canine and Feline Adoption Globally Accelerates Demand for Parvo, Distemper, and Rabies Immunizations
    • OEM Development of Intranasal and Oral Vaccine Formulations Improves Compliance and Reduces Stress
    • Rising Incidence of Vector-Borne Diseases in Companion Animals Strengthens Demand for Tick and Mosquito-Borne Vaccines
    • OEM Emphasis on Cold Chain Infrastructure and Vaccine Stability Supports Global Distribution Readiness
    • Growth in Veterinary Preventive Healthcare Plans Drives Regular Vaccination Schedules
    • OEM Advances in Adjuvant Technology and Immunomodulation Expand Duration of Immunity
    • Regulatory Support for Rabies Elimination Programs Fuels Public-Private Vaccine Initiatives
    • OEM Entry Into Pet Wellness Programs and Vaccine Subscription Models Strengthens Market Penetration
    • Increase in Global Travel With Pets Propels Demand for Travel-Required Vaccination Compliance
    • OEM Investment in Region-Specific Disease Surveillance Enhances Localized Vaccine Portfolio Development
    • Growth in Shelter Medicine and Animal Rescue Initiatives Drives Mass Vaccination Opportunities
    • OEM Focus on Genetic and Breed-Specific Immunization Strategies Expands Personalized Pet Health
    • Expansion of E-Commerce and Veterinary Telehealth Boosts Access to At-Home Vaccination Support Tools
    • Rising Incidence of Vaccine Hesitancy and Over-Vaccination Concerns Spurs Demand for Serological Titer Testing
    • OEM Participation in Global One Health Frameworks Enhances Alignment With Human and Animal Health Surveillance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pet Vaccines Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pet Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Pet Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Pet Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Canlane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Canlane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Canlane by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Feline by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Feline by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Feline by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Dogs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Dogs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Dogs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Cats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Cats by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Rabbits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Rabbits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Rabbits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Pet Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Pet Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Pet Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Pet Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Pet Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Pet Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Pet Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Pet Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Pet Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Pet Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Pet Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Pet Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Pet Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Pet Vaccines by Type - Canlane and Feline - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Pet Vaccines by Type - Canlane and Feline Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Pet Vaccines by Type - Percentage Breakdown of Value Sales for Canlane and Feline for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Pet Vaccines by Application - Dogs, Cats, Rabbits and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Pet Vaccines by Application - Percentage Breakdown of Value Sales for Dogs, Cats, Rabbits and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!